Table 1: Drugs Used in Immunocompetent and Immunocompromised Patients with Toxoplasmosis in the Setting of Acute Infection or Reactivation* (Primary Therapy)

Table 2: Drugs Used in Pregnant Women Who Have Likely Acquired T. gondii Infection During Gestation and Infants Suspected or Confirmed  to have Congenital Toxoplasmosis

Vignettes

Life Cycle of Toxoplasma gondii

Mege JL, Meghari S, Honstettre A, Capo C, Raoult D.  The Two faces of interleukin 10 in human infectious diseases.  Lancet Infectious Diseases 2006:7;557-569.

Review Article:  Adhikari P, Mietzner T.  Cell Mediated Immunity. 2008.

Review Article:  Radke et al. Host Cell-Directed Interactions with Toxoplasma Influence Pathogenesis. Microbe / Volume 2, Number 5, 2007.

Sobrin L, et al. Intravitreal clindamycin for toxoplasmic retinochoroiditis. Retina 2007;27:952-957.

Authors

Jose G. Montoya, M.D.,  Jacques Couvreur, M.D., Catherine Leport, M.D.